New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
10:01 EDTM, FRX, DHI, INSM, CACI, LLL, WSM, DAN, ANGI, HAL, VAL, TS, STI, ALB, AZN, D, DD, JCP, JNJ, MCD, MPW, PSA, RVBD, AETOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aetna (AET) upgraded to Outperform from Neutral at Credit Suisse... Albemarle (ALB) upgraded to Buy from Neutral at BofA/Merrill... AstraZeneca (AZN) upgraded to Hold from Underperform at Jefferies... Dominion (D) upgraded to Buy from Neutral at UBS... DuPont (DD) upgraded to Buy from Neutral at BofA/Merrill... J.C. Penney (JCP) upgraded to Overweight from Neutral at Piper Jaffray... Johnson & Johnson (JNJ) upgraded to Buy from Hold at Jefferies... McDonald's (MCD) upgraded to Overweight from Equal Weight at Morgan Stanley... Medical Properties Trust (MPW) upgraded to Buy from Hold at Jefferies... Public Storage (PSA) upgraded to Buy from Hold at Jefferies... Riverbed (RVBD) upgraded to Hold from Sell at Deutsche Bank... SunTrust (STI) upgraded to Neutral from Underperform at BofA/Merrill... Valspar (VAL) upgraded to Outperform from Neutral at RW Baird... Tenaris (TS) upgraded to Outperform from Sector Perform at Howard Weil... Halliburton (HAL) upgraded to Outperform from Sector Perform at Howard Weil... Forest Labs (FRX) upgraded to Buy from Neutral at Buckingham... D.R. Horton (DHI) upgraded to Buy from Neutral at MKM Partners... Insmed (INSM) upgraded at JMP Securities... CACI International (CACI) upgraded to Overweight from Neutral at JPMorgan... L-3 Communications (LLL) upgraded to Neutral from Underweight at JPMorgan... H&R Block (HRB) upgraded to Buy from Neutral at BTIG... Williams-Sonoma (WSM) upgraded to Buy from Hold at Argus... Dana Holding (DAN) upgraded to Buy from Neutral at Goldman... Angie's List (ANGI) upgraded at Raymond James... Macy's (M) upgraded to Outperform from Market Perform at BMO Capital.
News For AET;ALB;AZN;D;DD;JCP;JNJ;MCD;MPW;PSA;RVBD;STI;TS;VAL;HAL;FRX;DHI;INSM;CACI;LLL;WSM;DAN;ANGI;M From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
October 20, 2014
09:21 EDTHALHalliburton expects dividend to be be equal to at least 15%-20% of net income
Subscribe for More Information
09:15 EDTHALHalliburton: We do not see momentum slowing anytime soon
Halliburton should begin to see impact of new contract pricing as company moves into 2015. Experienced some disruptions in early Q3 due to sand deliveries and nearly missed jobs, but company said it has taken actions to "get ahead of this issue going forward." Says Eastern Hemisphere activity expanding at a steady rate, expects to deliver double digit revenue growth in 2014. Expects Q4 in Eastern Hemisphere to be strongest quarter of the year due to seasonality. Looking ahead to 2015, rate of growth in Eastern Hemisphere may moderate due geopolitical issues. Expects to outpace peers in revenue growth. Expects to be at full operational capacity in Mexico, and excited about energy reform in Mexico. Expects to operate under more profitable contract in Q1 for Brazil. Expects a "much stronger 2015" with potential in the coming years. In the long term, believes lower oil prices is not sustainable, with supply and demand to be back in balance in a relatively short amount of time. Comments taken from Q3 earnings conference call.
08:14 EDTJNJPharmacyclics files supplmeental NDA for Imbruvica for macroglobulinemia
Pharmacyclics (PCYC) announced that it has submitted a supplemental New Drug Application to the FDA based on data from a Phase 2 study evaluating the use of IMBRUVICA in patients with Waldenstrom's macroglobulinemia. IMBRUVICA, which received FDA Breakthrough Therapy Designation in February 2013 for patients with WM, is being jointly developed and commercialized by Pharmacyclics and Janssen Biotech (JNJ).
07:53 EDTSTISunTrust upgraded to Positive from Neutral at Susquehanna
Subscribe for More Information
07:50 EDTDHID.R. Horton initiated with a Neutral at Buckingham
Target $23.
07:47 EDTAZNPfizer less likely to renew Astra pursuit after Shire deal breakdown, FT says
Subscribe for More Information
07:19 EDTAZNIBC Life Sciences to hold a conference
Subscribe for More Information
07:16 EDTANGIAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
07:14 EDTAZNEuropean College of Neuropsychopharmacology to hold a conference
27th ECNP Congress is being held in Berlin, Germany on October 18-21.
07:03 EDTHALHalliburton reports Q3 C&P revenue $5.4B, D&E revenue $3.3B
Subscribe for More Information
07:02 EDTHALHalliburton reports Q3 EPS ex-items $1.19, consensus $1.10
Subscribe for More Information
06:55 EDTHALHalliburton board increases quarterly dividend by 20% to 18c
Subscribe for More Information
October 19, 2014
18:11 EDTMCDRussia temporarily suspends nine McDonald's restaurants in the country
Subscribe for More Information
October 17, 2014
16:55 EDTJCP, JNJStocks end volatile week lower amid oil price plunge
Subscribe for More Information
10:37 EDTJNJOptions with decreasing implied volatility: ATLS JNJ XLNX JNK HYG
Subscribe for More Information
08:57 EDTJNJPharmacyclics price target raised to $188 from $185 at Roth Capital
Subscribe for More Information
08:51 EDTJNJPharmacyclics announces European approval for Imbruvica
Subscribe for More Information
08:02 EDTJNJCovidien granted preliminary injunction against Ethicon's Harmonic ACE+7
Subscribe for More Information
06:39 EDTSTISunTrust intends to repurchase $230M of stock in next two quarters
Subscribe for More Information
06:06 EDTSTISunTrust reports Q3 EPS ex-items 81c, consensus 81c
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use